An Update from Our Firm about COVID-19

Abraham, Watkins, Nichols, Sorrels, Agosto, Aziz & Stogner remains fully operational and committed to serving our clients and colleagues throughout the Coronavirus (COVID-19) crisis. As we follow the CDC guidelines and practice social distancing, we remain available for phone consultations and scheduled in-person meetings with both current and prospective clients and colleagues. Please contact our office by email or by calling 713-222-7211 with any questions. We look forward to hearing from you.

Medtronic Infuse Bone Graft Settlement Ends Well For Victims

Photo of Muhammad Aziz

Recently, 950 plaintiffs settled with Medtronic a company that manufactured the "Infuse Bone Graft" for $22 million. A further $140 million is estimated to also settle about 3,800 additional claims.

Medtronic "continues to stand behind INFUSE bone graft" and does not admit liability in the settlement. The injuries spurred from off-label use of the product. The majority of the lawsuits claimed that Medtronic illegally promoted the Infuse off-label which means that the company allegedly claimed that the product could be used for non-FDA approved uses. Complications linked to the product included swelling of the airways, which could cause difficulty breathing, speaking, and swallowing. Medtronic Infuse has also been liked to retrograde ejaculation which could lead to male sterility.

An estimated 2,300 surgeons have used Medtronic products in the United States before any serious side effects were reported. A number of these doctors are facing medical malpractice lawsuits which include a failure to obtain informed consent and fraud. During the past 15 years, Medtronic has paid $210 million in royalties and other payments to a group of 13 doctors and two corporations linked to doctors. Many of the suits claim that it was by paying spinal surgeons, the company was able to promote the off-label use of Infuse.

If you or someone you know has been injured as a result of the Infuse Bone Graft, contact an attorney at Abraham, Watkins, Nichols, Sorrels, Agosto & Friend by calling 713-396-3964 or 1-800-594-4884.

No Comments

Leave a comment
Comment Information
  • $50+ Million Fire & Explosion

    The firm successfully represented nearly 100 victims who suffered personal injuries and damages to property from a large fire and explosion resulting in a settlement of more than $50 million. The firm served as lead lawyers on the steering committee in this litigation.

  • $80 Million Plant Explosion

    The firm successfully represented 270 plaintiffs, taking a lead role in the plaintiffs’ steering committee, who suffered injuries in a large plant explosion resulting in a settlement of nearly $80 million.

  • $50+ Million Plant Fire & Explosion

    The firm successfully represented 45 personal injury victims in a plant fire and explosion, serving on the plaintiffs steering committee, concluding with a settlement of more than $50 million.

  • $22+ Million Worksite Accident

    The firm prevailed in a personal injury trial for a worksite injury client with the jury returning a verdict and resulting in a judgment of over $22 million for the firm’s client.

  • $12 Million 18-Wheeler Collision

    The firm successfully achieved a $12 million settlement for the family of a man who died in an 18 wheeler collision.

  • $48 Million Catastrophic Burns

    The firm prevailed on behalf of three burn victims with settlements totaling nearly $48 million.

Our Record Of Success

When you are hurt and you choose a law firm to represent you in court or at the negotiation table, you need to carefully consider the firm's record.

Read More Success Stories

Let Us Help You Request a Free Consultation Today

Get Help Now

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Back to top